Protocols For Safe Use Of Sglt2I And Glp1Ra In The Hospital Setting

Protocols for Safe Use of SGLT2i and GLP1RA in the Hospital Setting

University of Ottawa Heart Institute

Safe and Effective Use of SGLT2i's and GLP-1RA's in Your Cardiology Practice

American College of Cardiology

Fundamentals of SGLT2i's and GLP-1RA's for CV Risk

American College of Cardiology

Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists

Harvard Medical School Continuing Education

The serendipitous story of SGLT2i in the treatment of heart failure

CSCS Canadian Society of Cardiac Surgeons

Choosing SGLT2 Inhibitors vs GLP-1 Receptor Agonists

Harvard Medical School Continuing Education

Team-Based Approach: Incorporating SGLT2i's and GLP-1RA's into Your Practice

American College of Cardiology

Early vs. Late Initiation of GLP-1RA and SGLT2 for Cardiometabolic Risk Control

SGLT-2 Inhibitors for Type 2 Diabetes - Amel Arnaout, MD

University of Ottawa Heart Institute

SGLT2 Inhibitors in Chronic Kidney Disease

Harvard Medical School Continuing Education

Is One SGLT2 (Or GLP-1) Just Like Another for Cardiac Benefit?

Initiating and Managing SGLT2 Inhibitors in Type 2 Diabetes Webinar

PG Debate on SGLT2 inhibitors Dr Prithvi and Dr Amit

Department of Medicine, CMC, Vellore

Managing your Medications

University of Ottawa Heart Institute

Taking Diabetes to Heart

University of Ottawa Heart Institute

Overview of the Heart and Heart Disease - Care after Discharge (part 2 of 7)

University of Ottawa Heart Institute

Should a Cariologist Prescribe the New SGLT-2 Diabetes Medications? by Amel Arnaout

University of Ottawa Heart Institute

SGLT2 Inhibition for the Prevention and Treatment of Kidney Disease in Patients With Type 2 Diabetes